ConductScience.org, home

Paper4895045

Electron-affinic sensitization. I. A structural basis for chemical radiosensitizers in bacteria.

Adams GE and 1 other. Int J Radiat Biol Relat Stud Phys Chem Med, 1969. Cited by 187 papers, by iCite.

Cite this record

ConductScience Library. Electron-affinic sensitization. I. A structural basis for chemical radiosensitizers in bacteria. Papers, record 4895045. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4895045

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Electron-affinic sensitization. I. A structural basis for chemical radiosensitizers in bacteria.
PubMed
Journal
Int J Radiat Biol Relat Stud Phys Chem Med
PubMed
Year
1969
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
187
iCite
Revised in PubMed
2019-08-29
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Adams GEG E
2Cooke MSM S

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Electron TransportMajor topic
Radiation-Sensitizing AgentsMajor topic
Serratia marcescensMajor topic
Fumarates
Models, Biological
Models, Chemical
Pyruvates
Quinones
Vitamin K

Source PubMed

Download CSV of topics

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 187 citations.

PMIDTitleJournalYearIn PapersSource
34827602Targeting Hypoxia: Revival of Old Remedies.Biomolecules2021https://conductscience.org/library/papers/34827602PubMed
34154610Interfering with Tumor Hypoxia for Radiotherapy Optimization.J Exp Clin Cancer Res2021https://conductscience.org/library/papers/34154610PubMed
30575832Hypoxia-targeted drug delivery.Chem Soc Rev2019https://conductscience.org/library/papers/30575832PubMed
30429888Hypoxia-responsive lipid-poly-(hypoxic radiosensitized polyprodrug) nanoparticles for glioma chemo- and radiotherapy.Theranostics2018https://conductscience.org/library/papers/30429888PubMed
29979089Clinical trials targeting hypoxia.Br J Radiol2019https://conductscience.org/library/papers/29979089PubMed
29303355Nitroimidazoles as hypoxic cell radiosensitizers and hypoxia probes: misonidazole, myths and mistakes.Br J Radiol2019https://conductscience.org/library/papers/29303355PubMed
28423594The hypoxia-activated prodrug evofosfamide in combination with multiple regimens of radiotherapy.Oncotarget2017https://conductscience.org/library/papers/28423594PubMed
28030900Tumor hypoxia and reoxygenation: the yin and yang for radiotherapy.Radiat Oncol J2016https://conductscience.org/library/papers/28030900PubMed
26983987The impact of hypoxia and its modification of the outcome of radiotherapy.J Radiat Res2016https://conductscience.org/library/papers/26983987PubMed
26073310Modulation of the tumor vasculature and oxygenation to improve therapy.Pharmacol Ther2015https://conductscience.org/library/papers/26073310PubMed
25243023The role of mitochondrial function in gold nanoparticle mediated radiosensitisation.Cancer Nanotechnol2014https://conductscience.org/library/papers/25243023PubMed
23149893Imaging hypoxia to improve radiotherapy outcome.Nat Rev Clin Oncol2012https://conductscience.org/library/papers/23149893PubMed
8763857Radioprotection by DNA ligands.Br J Cancer Suppl1996https://conductscience.org/library/papers/8763857PubMed
7013776Low concentrations of misonidazole counteract effects of extreme hypoxia on cells in S.Br J Cancer1981https://conductscience.org/library/papers/7013776PubMed
6768098Time effects in molecular radiation biology.Radiat Environ Biophys1980https://conductscience.org/library/papers/6768098PubMed
6168277Enhanced cytotoxicity of antineoplastic agents following prolonged exposure to misonidazole.Br J Cancer1981https://conductscience.org/library/papers/6168277PubMed
465301Ascorbate anion potentiates cytotoxicity of nitro-aromatic compounds under hypoxic and anoxic conditions.Br J Cancer1979https://conductscience.org/library/papers/465301PubMed
375966Radiosensitization of E. coli B/r by the cytotoxic agent procarbazine: a hypoxic cell sensitizer preferentially toxic to aerobic cells and easily oxidized.Br J Cancer1979https://conductscience.org/library/papers/375966PubMed
354671A possible combination of hypoxic cell sensitizer with an oxic protector: implications for radiotherapy.Br J Cancer1978https://conductscience.org/library/papers/354671PubMed
277207The rationale for the development of improved hypoxic cell radiosensitizers.Br J Cancer Suppl1978https://conductscience.org/library/papers/277207PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4895045

GET https://conductscience.org/api/papers/v1/4895045/authors